DIFFERENCES IN THE TOTAL HEALTHCARE COSTS DURING THE YEAR OF DIAGNOSIS BETWEEN APPALACHIAN AND A NATIONAL COHORT OF ELDERLY WOMEN WITH BREAST CANCER- AN APPLICATION OF DECOMPOSITION TECHNIQUE
Author(s)
Vyas A1, Madhavan SS2, Sambamoorthi U2, Pan X3, Regier M2, Hazard H2
1Rutgers University, Piscataway, NJ, USA, 2West Virginia University, Morgantown, WV, USA, 3Evidera LLC, Lexington, MA, USA
OBJECTIVES: The primary objectives of this study were to estimate the average costs during the initial phase of care (year of diagnosis) among West Virginia (WV)-Medicare beneficiaries with breast cancer (BC) and compare it with the national estimates from the Surveillance, Epidemiology, End Results (SEER)-Medicare database using a linear decomposition technique. METHODS: A retrospective observational study was conducted where the study cohorts consisted of elderly women age > 66 with incident BC between 2003 and 2006 in WV-Medicare and SEER-Medicare. Total costs were the actual medical payments for all services derived from Medicare files. Generalized linear regressions with log link and gamma distribution were performed. Blinder-Oaxaca decomposition was conducted to examine the extent to which predisposing, enabling, need-related, healthcare use and external healthcare environmental factors contributed to the differences in the average costs. RESULTS: Total average costs for WV-Medicare cohort during the initial phase of care were lower ($19,875) as compared to the SEER-Medicare cohort ($22,881), a difference of $3,006. After adjusting for other factors, the difference was $549 and remained significant. Only 16% of the difference in the average costs between the two cohorts were explained by the independent variables included in the model. Enabling resources (6.85%), healthcare use (7.53%) explained most of the differences in costs. CONCLUSIONS: Total average costs of BC care were lower in a rural state compared to the national estimates. The differences in the costs were not explained by the patient-level factors included in the model.
Conference/Value in Health Info
2015-05, ISPOR 2015, Philadelphia, PA, USA
Value in Health, Vol. 18, No. 3 (May 2015)
Code
PHS29
Topic
Economic Evaluation
Topic Subcategory
Cost/Cost of Illness/Resource Use Studies, Cost-comparison, Effectiveness, Utility, Benefit Analysis
Disease
Oncology